Last $6.14 USD
Change Today -0.07 / -1.13%
Volume 492.0K
As of 8:04 PM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James T. Glover

Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee, Organovo Holdings, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 3 different industries.

See Board Relationships
64$191,016

Background*

Mr. James T. Glover served as the Chief Financial Officer and Senior Vice President of Operations at Anadys Pharmaceuticals Inc. from September 25, 2006 to September 2009 and served as its Principal Accounting Officer until September 2009. Mr. Glover served as Chief Financial Officer and Senior Vice President of Beckman Coulter Inc. from March 19, 2004 and July 12, 2005 respectively to June 30, 2006. He held several Financial Management positions at Beckman Coulter Inc. ...

Read Full Background

Corporate Headquarters*

6275 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-550-9994
Fax: --

Board Members Memberships*

Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
2012-Present
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

BS
California State Polytechnic University, Pomona
Master's Degree
Pepperdine University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$67,000
Total Calculated Compensation$191,016
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONVO:US $6.14 USD -0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$406.6K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Lode Debrabandere Ph.D., MBAChief Executive Officer, President and Director
Osiris Therapeutics, Inc.
$366.8K
Paul K. Wotton Ph.D.Chief Executive Officer, President, Director and Member of Pricing Committee
Advanced Cell Technology Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORGANOVO HOLDINGS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.